Tuners Edge

https://www.anocca.com › company › about
Anocca was founded in 2014 to build biotechnologies processes and infrastructure needed to decode T cell immunity with the ambition to build new forms of T cell immunotherapies

https://www.linkedin.com › company › anocca-ab
Anocca is a fully integrated biopharmaceutical company that develops libraries of T cell receptor engineered T cell TCR T therapies to redefine the treatment of solid tumours and other

https://www.biospace.com › press-releases › anocca-has-dosed-first...
Anocca is a fully integrated clinical stage biopharmaceutical company that develops libraries of T cell receptor modified T cell therapies TCR T to redefine the treatment of solid

https://www.thepharmaletter.com › anocca
In March 2025 Anocca gained regulatory clearance to begin its first in human study positioning the firm as a newly clinical stage biotech

https://www.eib.org › en › projects › all
Anocca s expertise lies in the discovery of T cell receptor engineered T cell therapies TCR T with optimised properties to address specific limitations of existing therapeutic approaches

https://pitchbook.com › profiles › company
Information on valuation funding cap tables investors and executives for Anocca Use the PitchBook Platform to explore the full profile

https://european-biotechnology.com › latest-news
Swedish immunoncology specialist Anocca AB has raised SEK440m 38 36m ahead of enrolling pancreatic cancer patients in a Phase I umbrella trial evaluating the safety of its T cell

https://www.nature.com › articles
Memorable distinctive not too sciencey why we named our biotech firm Anocca Chief executive Reagan Jarvis describes the role a branding agency had in naming his technology company

https://www.cellgenetherapyreview.com
Swedish biopharma Anocca raised approximately 46 million in financing which it will use to progress its gene edited T cell receptor engineered T cell TCR T therapy targeting mutant